Himachal Dental

SimPlant Crystal – Predictable Dental Implant Treatment

Posted in Dental News by UK Dental Tourism on December 21, 2009

SimPlant Crystal, is the latest software version of Materialise Dental’s highly-acclaimed SimPlant software.

SimPlant offers you a fully integrated dental implant treatment planning tool that visualizes your patient’s anatomy with unparalleled precision – in 3D. As a SimPlant user, you will have no problem with finding the ideal position of the implants, while taking into account both clinical and esthetical considerations.

*Instant Insights and Crystal Clear Images
When it comes to diagnostics and treatment planning, you need images of unrivaled clarity to work with. In comes SimPlant  Crystal – providing you with crystal clear images from CT and cone beam scanners.

*Easy-to-Use and Universally Compatible
SimPlant Crystal is easy to work with, it’s even compatible with all CT scanners, cone beam scanners and implant brands on the market. And multiple SurgiGuide drill guide solutions provide a more time and cost-efficient way to realize esthetic perfection.

The beauty of SimPlant is that you have a fundamentally simple tool which will guide you step by step during your implant planning. As such, you can comprehensively plan a case with ease and confidence. This tool can further be used to communicate with your patients in a way that they understand what you plan to do and how you plan to do it.From scan to plan to guide, to the ultimate Immediate Smile, SimPlant Crystal gives clinicians the opportunity to plan their surgery time more efficiently, accept more referrals and enjoy a higher revenue on even the most complex cases. It also allows them to continue working with the implant brands and scanning equipment they already know and use.

New Vaccine To Treat Periodontal Disease

Posted in Dental News by UK Dental Tourism on December 20, 2009
Tags: ,

Periodontitis refers to a number of inflammatory diseases affecting the periodontium — that is, the tissues that surround and support the teeth. Periodontitis involves progressive loss of the alveolar bone around the teeth, and if left untreated, can lead to the loosening and subsequent loss of teeth. Periodontitis is caused by microorganisms that adhere to and grow on the tooth’s surfaces, along with an overly aggressive immune response against these microorganism.Up to 30% of  adults suffer from the wide-spread gum disease, which causes gums to bleed and teeth to fall out. The condition has also been linked with heart disease, stroke, adverse pregnancy outcomes, dementia and cancer.

A diagnosis of periodontitis is established by inspecting the soft gum tissues around the teeth with a probe and x-ray films by visual analysis, to determine the amount of bone loss around the teeth. The cornerstone of successful periodontal treatment starts with establishing excellent oral hygiene. This includes twice daily brushing with daily flossing.Traditional treatment for the disease often involves scaling and cleaning, and even surgery .Periodontitis is a serious disease and dentists face a major challenge in treating it.

Scientists in the Cooperative Research Centre for Oral Health Science from The University of Melbourne have identified candidate vaccine antigens for the wide-spread gum disease periodontitis.CSL Limited, Australia’s leading biopharmaceutical company, has announced that a vaccine to treat severe gum disease is being developed in a new collaboration with Sanofi Pasteur, the world’s leading global manufacturer of vaccines.

Following more than ten years of research, scientists from The University of Melbourne and CSL, in the Cooperative Research Centre for Oral Health Science have identified candidate vaccine antigens for periodontitis.
This new vaccine approach targets the ‘ring leader’ of a group of pathogenic bacteria that cause periodontitis, the bacterium called Porphyromonas .CSL is in agreement with Sanofi Pasteur to undertake a funded program to develop a vaccine for the treatment of periodontal disease caused by Porphyromonas gingivalis.

It will provide dentists and patients with a specific treatment, which prevents disease progression, rather than managing its symptoms and damaging consequences.Ultimately, it is anticipated these findings could lead to the development of early interventional therapy or prevent the disease from starting.Click here to read the press release.

Dentists Can Help Identify Patients With Heart Disorders

Dentists can help to identify patients who are in danger of dying of a heart attack or stroke, reveals a new study from the Sahlgrenska Academy. Thanks to the study, six men who thought they were completely healthy were able to start preventive treatment in time.

‘Dentists are really proud of their profession and feel no need to encroach upon doctors’ territory,’ says senior dental officer and professor Mats Jontell at the Sahlgrenska Academy. ‘However, we wanted to find out if we as a profession could identify patients at risk of cardiovascular disease.’

The study involved 200 men and women over the age of 45 who did not have any known cardiovascular problems. During a routine visit to their normal dentists in Boras and Gothenburg they were also checked out for known risk factors for cardiovascular disease.

‘These risk factors are not normally manifested in the mouth, which is why the dentists went beyond their normal check-up routine,’ says Jontell. ‘They also took the patients’ blood pressure and checked total cholesterol and blood sugar levels.’

The risk of a fatal cardiovascular disease was calculated using a software known as HeartScore. The dentists felt that twelve men had a ten per cent risk of developing a fatal cardiovascular disease over the next ten years and advised them to see their doctors. Six of the twelve were subsequently prescribed medication to lower their blood pressure.

‘Dentists regularly see a very large percentage of the Swedish population, and if there is sufficient interest they could also screen for cardiovascular risk factors which, untreated, could lead to a heart attack or stroke,’ says Jontell.(Reported ScienceDaily Nov. 25, 2009)

Historically, the American Heart Association (AHA) recommend prophylactic antibiotics for anyone with MVP, to be delivered prior to dental surgery or even cleaning. The theory was that such treatment would preemptively inhibit bacterial infection as a result of septic dental plaque seeping into the bloodstream. Although the theory may have been correct, the AHA recently concluded that the risk inherent in taking antibiotics actually exceeded the risk eliminated by preventing this very isolated, rare source of endocarditis. Antibiotic overuse runs of risk of resistant bacterial infection, liver stress, and the destruction of one’s beneficial gut bacteria which serve as part of our digestive and immune systems.

Prophylaxis for Dental Procedures Against Bacterial Endocarditis :

Regimen A : Penicillin

* Adults : Penicillin V (2 g orally 30 minutes to 1 hour prior to procedure and then 500 mg every 6 hours for 8 doses)

Regimen B : Penicillin plus Streptomycin

* Adults : Aqueous crystalline Penicillin G (1.000.000 U intramuscularly) mixed with procaine penicillin G (600.000 U intramuscularly) plus streptomycin (1 g intramuscularly).
* Give 30 minutes to 1 hour prior to the procedure, then penicillin V 500 mg orally every 6 hours for 8 doses

« Previous Page

%d bloggers like this: